Bixiye
QP8-20 Medical Drug Update for New to Market Golodirsen (Vyondys 53)
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2221 - 2230 ee natiijooyinka 3613
Bixiye
QP25-20 Pharmacy Benefit Exclusion for Injectafer®, Feraheme®, Venofer®, INFeD®, Ferrlecit®, and generic Ferrlecit®
Taariikhda uu dhaqangalayo Barnaamijka: Mar 11, 2020
Bixiye
QP26-20 CMS Decision Memo on Acupuncture for Chronic Low Back Pain
Taariikhda uu dhaqangalayo Barnaamijka: Mar 11, 2020
Bixiye
QP24-20 Pharmacy Benefit Update – Addition of Drugs to Existing Prior Authorization (PA) with Quantity Limit (QL) Programs
Taariikhda uu dhaqangalayo Barnaamijka: Mar 11, 2020
Bixiye
QP8R1-20 Update: Medical Drug Update for Golodirsen (Vyondys 53)
Taariikhda uu dhaqangalayo Barnaamijka: Mar 11, 2020
Bixiye
P20-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: Mar 02, 2020
Bixiye
P19-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates - Effective May 4, 2020
Taariikhda uu dhaqangalayo Barnaamijka: Mar 02, 2020
Bixiye
P16-20 eviCore CPT Code Updates for Medicare Advantage Subscribers- eviCore Healthcare Specialty Utilization Management (UM) – Durable Medical Equipment
Taariikhda uu dhaqangalayo Barnaamijka: Mar 02, 2020
Bixiye
2020 March Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: Mar 02, 2020
Bixiye
P18-20 Lab Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Taariikhda uu dhaqangalayo Barnaamijka: Mar 02, 2020